ABOUT THIS STUDY
- Diagnosis of IPF based on American Thoracic Society (ATS) guidelines
- Subjects with end-stage
- Previous treatment with etanercept or other TNF antagonists (eg, a TNF monoclonal
antibody or a soluble TNF-receptor)
- Receipt of any investigational drug or biological agent within 4 weeks of screening
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.